MRX Fair Value Estimate
$149.05165.1% undervalued
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
MRX
Marex Group Plc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Marex Group Plc
Current Price
$56.22
-1.99%GoodMoat Value
$149.05
165.1% undervaluedProfile
Valuation (TTM)
Market Cap$4.10B
P/E13356822.68
EV—
P/B3.52
Shares Out72.94M
P/Sales2471696.54
Revenue$1659.00
EV/EBITDA—
Marex Group Plc (MRX) Valuation
MRX Valuation Metrics
FCF$654.40M
FCF Growth Rate7.76%
EPS Growth (CAGR)50.00%
WACC10.00%
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →MRX Valuation & Fair Value Analysis
Marex Group Plc (MRX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Marex Group Plc is $149.05. The current stock price is $56.22, suggesting the stock is 165.1% undervalued.
The price-to-earnings (P/E) ratio is 13356822.68. Price-to-book ratio is 3.52. Price-to-sales ratio is 2471696.54.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Marex Group Plc's intrinsic value.